<< Back To Products
U.S. Baxter Product Catalog
U.S. eServices Center
Anesthesia
Biopharmaceuticals
Medication Management
Blood Collection and Transfusion
Oncology
Renal
Material Safety Data Sheets
Technical Support
Baxter provides purified plasma treatments containing antibodies called immunoglobulins that help Primary Immune Deficiency patients fight off infection. Immunoglobulins are also indicated to treat a number of conditions including Kawasaki Syndrome, Chronic Lymphocytic Leukemia (CLL) and Idiopathic Thrombocytopenic Purpura (ITP).
Our mission is to improve surgical practice by the development and use of biomaterials for hard and soft tissue repair, and the complex challenges of surgery
Baxter’s vast experience in plasma fractionation has resulted in reliable and innovative therapeutics developed from human serum albumin to support these patients.
Our long-standing commitment to provide high-quality therapies for people with hemophilia has led to innovations including monoclonal antibody purification and heat treatment processes, introduction of the first recombinant Factor VIII therapy, and most recently, of the first plasma/albumin-free method recombinant Factor VIII therapy.
Print this page
